Q2Earth Signs Exclusive Option Agreement to License Promising Drug to Treat Bone Cancer in Children
22 janv. 2020 09h00 HE
|
Q2Earth, Inc
Palm Beach, FL, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that it has signed an Exclusive Dealing Option Agreement to provide the Company...